|
Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer Clinical research trials and Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer. Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer clinical trial. Subjects frequently obtain the most expert healthcare possible for their Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "L" Clinical Trials Conditions > Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer  Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
For Condition: stage 3 prostate cancer,stage 2 prostate cancer,stage 4 prostate cancer,stage 1 prostate cancer,adenocarcinoma of the prostate
Status: Recruiting
Sponsor(s): Jonsson Comprehensive Cancer Center , National Cancer Institute (NCI)
Synopsis: RATIONALE: A low-fat, high-fiber diet may slow the growth of prostate cancer. PURPOSE: Randomizedphase II trial to compare the effectiveness of a low-fat, high-fiber diet with that of a standard diet in treating patients who have prostate cancer.
Details: OBJECTIVES: - Compare the inhibition of growth of human prostate cancer cell lines by serum from patients with prostate cancer before and after being fed a low fat, high fiber diet. - Determine the underlying mechanism through which a low fat, high fiber diet affects the growth of prostate cancer cell lines. - Determine whether a low fat, high fiber diet inhibits the growth of prostate cancer cell lines through androgen-dependent and/or androgen- independent mechanisms in these patients. - Determine the growth factors, hormones, and/or binding proteins that may be responsible for affecting the growth of prostate cancer cell lines in these patients. OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 arms. - Arm I: Patients receive a low fat, high fiber diet daily for 3 weeks. - Arm II: Patients receive a control diet containing the standard amounts of fat and fiber. PROJECTED ACCRUAL: A total of 40 patients (20 per arm) will be accrued for this study within 6 months.
Eligibility:
Study Type: Interventional, Prevention
Minimum Age/Maximum Age: 40 Years/80 Years
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Diagnosis of adenocarcinoma of the prostate - Previously untreated and on watchful waiting - Medically able to receive dietary intervention PATIENT CHARACTERISTICS: Age: - 40 to 80 Performance status: - Not specified Life expectancy: - Not specified Hematopoietic: - Not specified Hepatic: - Not specified Renal: - Not specified Other: - Must be willing to travel to UCLA 3 days a week for 4 weeks to obtain specially prepared foods PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - No concurrent luteinizing hormone-releasing hormone agonists (leuprolide or goserelin) - No concurrent androgen-receptor blocking agents (flutamide or bicalutamide) - No concurrent testosterone - No concurrent insulin - No concurrent finasteride Radiotherapy: - Not specified Surgery: - No prior orchiectomy Other: - No concurrent saw palmetto supplement
Total Enrollment:
Location and Contact Information:
Overall Study Official:
WilliamAronson, Study Chair, Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center, UCLA *Recruiting*
Los Angeles, California, 90095-1738
United States
Recruiting William Aronson 310-268-3446
Additional Information:
Study ID Numbers: CDR0000068737; UCLA-0001030,NCI-G01-1973
Study Start Date:
Record last reviewed: November 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00020995
Other Stage 1 Prostate Cancer Studies:
1. Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
2. Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
3. TG4010 in Treating Patients With Prostate Cancer
4. Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
5. Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
Related Studies:
Other stage 1 prostate cancer Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials
Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
|
|
|
|
|
|
|
|
